Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Claudio, J Salomon"'
Autor:
Diego Dusso, Claudio J. Salomon
Publikováno v:
Journal of Food Science. 88:1495-1505
Autor:
Marcela S Rial, María L Scalise, Eva C Arrúa, Mónica I Esteva, Claudio J Salomon, Laura E Fichera
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 11, Iss 12, p e0006119 (2017)
Chagas disease is a neglected parasitic infection caused by the protozoan Trypanosoma cruzi (T. cruzi) that affects more than 6 million people, mainly in Latin America. Benznidazole is still the drug of choice in many countries to treat it in spite o
Externí odkaz:
https://doaj.org/article/a7527d3cbc734b188dd94b387bfeb5ed
Autor:
Katia Pamela Seremeta, Laura Edith Fichera, Marcela Silvina Rial, Jacqueline Búa, Mónica Inés Esteva, Claudio J. Salomon
Publikováno v:
Parasitology. 148:566-575
Chagas disease is a serious parasitic infection caused by Trypanosoma cruzi. Unfortunately, the current chemotherapeutic tools are not enough to combat the infection. The aim of this study was to evaluate the trypanocidal activity of benznidazole-loa
Autor:
Claudio J. Salomon, Eva Carolina Arrua, N G Prado, Jacqueline Búa, Laura Edith Fichera, Susana A. Laucella, María Ailén Natale, M I Esteva, M S Rial
Publikováno v:
Journal of Antimicrobial Chemotherapy. 75:1906-1916
Background Benznidazole and nifurtimox are effective drugs used to treat Chagas’ disease; however, their administration in patients in the chronic phase of the disease is still limited, mainly due to their limited efficacy in the later chronic stag
Autor:
Eva C. Arrua, Olga Hartwig, Brigitta Loretz, Héctor Goicoechea, Xabier Murgia, Claus-Michael Lehr, Claudio J. Salomon
Publikováno v:
Colloids and surfaces. B, Biointerfaces. 217
Chagas disease is a neglected tropical disease affecting the American continent and also some regions of Europe. Benznidazole, approved by FDA, is a drug of choice but its poor aqueous solubility may lead to a low bioavailability and efficacy. Theref
Publikováno v:
Molecules, Vol 5, Iss 3, Pp 252-282 (2000)
This Paper is downloadable at http://www.mdpi.org/molecules/papers/50300252.pdf
Externí odkaz:
https://doaj.org/article/c9b7065cb4704739917377c9db8c0cc1
Autor:
Eva C, Arrua, Olga, Hartwig, Duy-Khiet, Ho, Brigitta, Loretz, Xabier, Murgia, Claudio J, Salomon, Claus-Michael, Lehr
Publikováno v:
Pharmaceutical research. 38(6)
The aim of this work was to formulate and characterize surfactant-free glibenclamide nanoparticles using Eudragit RLPO and polyethylene glycol as sole stabilizer.Glibenclamide nanoparticles were obtained by nanoprecipitation and evaluated in terms of
Elucidating the Splitting Behavior of Tablets to Optimize the Pharmacotherapy in Veterinary Medicine
Autor:
Claudio J. Salomon, Livia L. Sa-Barreto, Juliano A. Chaker, Nora Beatriz Okulik, Marcilio Cunha-Filho, Felipe Q. Pires, Giselle Rocio Bedogni, Katia Pamela Seremeta
Publikováno v:
AAPS PharmSciTech. 22
It is well known that the splitting of tablets can bring serious risks to the health of the treated animals, e.g., the possible adverse reactions caused by overdoses of fenbendazole or aspirin. In this regard, this work aimed to evaluate, for the fir
Autor:
Xabier Murgia, Olga Hartwig, Claudio J. Salomon, Brigitta Loretz, Claus-Michael Lehr, Duy-Khiet Ho, Eva Carolina Arrua
Publikováno v:
Pharmaceutical Research
The aim of this work was to formulate and characterize surfactant-free glibenclamide nanoparticles using Eudragit RLPO and polyethylene glycol as sole stabilizer. Glibenclamide nanoparticles were obtained by nanoprecipitation and evaluated in terms o
Autor:
Claudio J. Salomon
Publikováno v:
Molecules, Vol 10, Iss 1, Pp 3-5 (2005)
n/a
Externí odkaz:
https://doaj.org/article/8ea3b1a663f449ada060360ca88fb94b